I and my colleagues, Eric Westman at Duke and Miriam Vincent, Chair of Family Medicine at Downstate Medical Center will be applying for the Challenge Grants and other NIH programs. We are also trying to work with the NIH to make sure we get a fair review. Our particular focus: minorities have suffered disproportionately in the epidemic of diabetes and obesity and this is no more evident than in Brooklyn where we intend to treat an urban Black population with diabetes with low carb diets.
This is one of the areas where government is at least part of the solution to the problem in that the research is expensive and the government is best at it. The NIH has a history of great contribution to biomedical research. Right now, it has many problems, and in the area of interest, it still is overly represented by proponents of low-fat diets and drugs-first philosophy. The NIH, however, is working hard at self-correction and I think there is cause for optimism.
Also, not to detract from the trenchant critique of low fat, Taubes's book does not correctly explain where low carbohydrate ideas come from, namely, recent research notably from basic research on metabolism which is in the biochemistry textbooks and its application in work from Eric Westman and Jeff Volek, which Taubes inexplicably ignores. In any case, the hypothesis is laid out in papers in Nutrition and Metabolism (available without subscription):
http://www.nutritionandmetabolism.c...3-7075-2-31.pdf
http://www.nutritionandmetabolism.c...3-7075-3-24.pdf
http://www.nutritionandmetabolism.c...43-7075-5-9.pdf
Most recently, these hypothesis have been tested in a prospective trial in Jeff Volek's lab, details will be available on the Metabolism Society's website:
http://www.nmsociety.org In brief,
Two hypocaloric diets (about 1,500 kcal) were compared: a carbohydrate-restricted diet (CRD) (%carbohydrate: fat
rotein = 12:59:28) and a low-fat diet (LFD) (56:24:20) in 40 subjects with metabolic syndrome (MetS), specifically atherogenic dyslipidemia (high triglycerides, low HDL, more small dense LDL). Subjects following the CRD had consistently greater improvements in glucose, insulin, insulin sensitivity, weight loss and more favorable changes in triglycerides, HDL-Cand total cholesterol/HDL-C. Notably, despite a threefold higher intake of dietary saturated fat during the CRD, saturated fatty acids in the blood were significantly decreased. “The findings provide support for unifying the disparate markers of MetS and for the proposed intimate connection with dietary carbohydrate. The results support the use of dietary carbohydrate restriction as an effective approach to improve features of MetS and cardiovascular risk.